During the last session, Rocket Pharmaceuticals Inc (NASDAQ:RCKT)’s traded shares were 1.96 million, with the beta value of the company hitting 1.08. At the end of the trading day, the stock’s price was $26.81, reflecting an intraday loss of -1.72% or -$0.47. The 52-week high for the RCKT share is $32.53, that puts it down -21.34 from that peak though still a striking 44.46% gain since the share price plummeted to a 52-week low of $14.89. The company’s market capitalization is $2.43B, and the average intraday trading volume over the past 10 days was 0.77 million shares, and the average trade volume was 799.48K shares over the past three months.
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) trade information
Rocket Pharmaceuticals Inc (RCKT) registered a -1.72% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.72% in intraday trading to $26.81, hitting a weekly high. The stock’s 5-day price performance is -3.80%, and it has moved by -7.23% in 30 days. Based on these gigs, the overall price performance for the year is 48.86%. The short interest in Rocket Pharmaceuticals Inc (NASDAQ:RCKT) is 9.96 million shares and it means that shorts have 13.24 day(s) to cover.
Rocket Pharmaceuticals Inc (RCKT) estimates and forecasts
Statistics show that Rocket Pharmaceuticals Inc has underperformed its competitors in share price, compared to the industry in which it operates. Rocket Pharmaceuticals Inc (RCKT) shares have gone up 11.48% during the last six months, with a year-to-date growth rate less than the industry average at -0.68% against 13.20. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 6.80% this quarter and then jump 13.40% in the quarter after that.
Meanwhile, a consensus of 8 analyst(s) estimates revenue growth to $2.42 million by the end of Jun 2024.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -9.09%. While earnings are projected to return 7.00% in 2024, the next five years will return 41.70% per annum.
RCKT Dividends
Rocket Pharmaceuticals Inc is due to release its next quarterly earnings between May 02 and May 06. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Rocket Pharmaceuticals Inc (NASDAQ:RCKT)’s Major holders
Rocket Pharmaceuticals Inc insiders own 3.63% of total outstanding shares while institutional holders control 100.87%, with the float percentage being 104.66%. RTW Investments LP is the largest shareholder of the company, while 296 institutions own stock in it. As of Jun 29, 2023, the company held over 17.69 million shares (or 21.97% of all shares), a total value of $351.46 million in shares.
The next largest institutional holding, with 5.14 million shares, is of Wellington Management Group, LLP’s that is approximately 6.39% of outstanding shares. At the market price on Jun 29, 2023, these shares were valued at $102.18 million.
Also, the Mutual Funds coming in first place with the largest holdings of Rocket Pharmaceuticals Inc (RCKT) shares are Vanguard Specialized-Health Care Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. Data provided on Jul 30, 2023 indicates that Vanguard Specialized-Health Care Fund owns about 2.57 million shares. This amounts to just over 3.19 percent of the company’s overall shares, with a $46.41 million market value. The same data shows that the other fund manager holds slightly less at 1.96 million, or about 2.44% of the stock, which is worth about $30.74 million.
